Call 888-647-0579 to speak with an alcohol or drug abuse counselor.

Who Answers?

Cancer Immunotherapy Shows Long-Term Promise In Lung Cancer

New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery — to the same extent as chemotherapy but without the side-effects of chemotherapy.

Prof. Johan Vansteenkiste from University Hospital Gasthuisberg in Belgium described the results after 44-months follow-up from a double-blind, placebo-controlled trial in 182 patients with non-small-cell lung cancer — the most common form of the disease.

After complete surgical resection of the tumor, patients were randomly assigned to receive either placebo injections or injections of MAGE-A3 ASCI administered over 27 months (five given at three-week intervals followed by eight given once every three months).

MAGE-A3 is a tumor-specific antigen, expressed in 35-50% of non-small-cell lung cancer, but not on normal cells.

“The aim is to help the body immune system to recognize the MAGE-A3 antigen and therefore eliminate the cancer cells that express MAGE-A3,” explains Prof. Vansteenkiste. “In other words, it is a kind of treatment method that makes the body immune system specifically attack the lung cancer cells.”

After 44 months, 69 of 182 patients had experienced a recurrence of their cancer, including 57 deaths. Those given the MAGE-A3 injections had longer on average before their cancer recurred, were less likely to have any recurrence, and were less likely to die.

“Surgical resection is the standard treatment for patients with early stage lung cancer, but after complete resection about 50% will relapse and die from their cancer,” says Prof. Vansteenkiste. “Postoperative chemotherapy is able to improve cure rates, but is sometimes poorly tolerated by patients recovering from thoracic surgery. In addition, not all patients are fit to receive chemotherapy. This is why the signal from this phase II randomized study is important: the reduction in risk of postoperative cancer relapse is similar to the one obtained with postoperative chemotherapy, while the side-effects of this new strategy are minimal compared to chemotherapy.”

Most patients only experience mild reactions at the injection site and fever within 24 hours of the injection, he explained. “Therefore, it is suitable for long-term maintenance treatment and for most patients, including older patients or patients in weak physical condition after surgery, allowing them to live a normal life whilst on cancer treatment.” A large Phase III trial of the therapy, named MAGRIT, is now underway.

source: http://www.esmo.org/

More Treatment & Detox Articles

Alcohol effects during adolescence

The festive season has come and gone. The fun will forever be cherished by those who had a fabulous time. Some will forever cherish the fun they had while others will reflect at the bad things they did. It is definitely an indisputable fact that some young blades are now addicted to the things they….

Internet addiction may be one click away

The Internet is where we spend more and more of our time. But for a growing number of people, it’s an out-of-control habit instead of a necessary part of life. Internet addiction — an online-related compulsive behavior that interferes with normal living and causes severe stress on family, friends, loved ones and work — is….

Drug addiction

“Drugs” is not a respected word in our dictionary. Scientifically, drugs are small fine substances that are very effective in modifying the normal regular functions of a body. The different types of drugs are identified in three basic categories namely “depressants”, “stimulants” and “hallucinogens”. Drugs are widely used by doctors and hospitals, in required proportions….

The language of intoxication: The term 'drunk' doesn't really cut it any more

The language that drinkers typically use to describe alcohol’s effects on them are quite different from the language used by alcohol researchers, no doubt limiting researchers’ understanding of self-reported alcohol use. New findings show that researchers could do well to tap into a wide spectrum of terms used by drinkers to describe their levels of….

Most substance abusers seek treatment for drugs

People who go into substance-abuse treatment in North Carolina are more likely to be involved with drugs than with alcohol, according to a new federal report released today. However, help is more easily available for alcohol abuse, the report says. During the past 15 years, the report says, more North Carolinians are being admitted to….